All systems operational
Q2 2021

Antofloxacin-based bismuth quadruple therapy is safe and effective in Helicobacter pylori eradication: A prospective, open-label, randomized trial

Xiao-Jian He · Xiang-Peng Zeng · Chuan-Shen Jiang · Gang Liu · Da-Zhou Li · Wen Wang
10.1016/j.ajg.2020.09.005 385 Views 6 Citations
6
Citations
385
Views
Abstract not available for this publication.
Cite this Article (APA)
Xiao-Jian, H., Xiang-Peng, Z., Chuan-Shen, J., Gang, L., Da-Zhou, L., Wen, W. (2021). Antofloxacin-based bismuth quadruple therapy is safe and effective in Helicobacter pylori eradication: A prospective, open-label, randomized trial. Arab Journal of Gastroenterology. https://doi.org/10.1016/j.ajg.2020.09.005
Related Papers
ChatGPT’s ability to comprehend and answer cirrhosis related questions in Arabic
Jamil S. Samaan; Yee Hui Yeo; Wee Han Ng; Peng-Sheng Ting; Hirsh Trivedi; Aarshi · 2023
35
cites
390
20
cites
388
Short-term orlistat therapy improves fatty infiltration indices and liver fibrosis scores in patient…
Vian Ahmed Wasta Esmail; Mohammed Omer Mohammed; Marwan S.M. Al-Nimer · 2021
19
cites
388
Red cell distribution width to serum albumin ratio as an early prognostic marker for severe acute pa…
Xianling Wang; Liye Zhu; Kunlin Tao; Caiying Bi; Mengbin Qin; Guodu Tang; Jiean · 2022
19
cites
387
Access
View Full Text via DOI
Published in
ISSN 1687-1979
Quartile Q2
AMS Score 91
Field Medicine & Health Sciences
Publisher Elsevier
Country 🇪🇬 Egypt
View Journal Profile →
Authors
Publication Details
Year 2021
Language English
Added 01 Aug 2026